@article{98597,
  keywords = {Infectious Diseases, Microbiology (medical), Immunology, Microbiology},
  author = {Klever AM and Alexander KA and Almeida D and Anderson MZ and Ball RL and Beamer G and Boggiatto P and Buikstra JE and Chandler B and Claeys TA and Concha AE and Converse PJ and Derbyshire KM and Dobos KM and Dupnik KM and Endsley JJ and Endsley MA and Fennelly K and Franco-Paredes C and Hagge DA and Hall-Stoodley L and Hayes D and Hirschfeld K and Hofman CA and Honda JR and Hull NM and Kramnik I and Lacourciere K and Lahiri R and Lamont EA and Larsen MH and Lemaire T and Lesellier S and Lee NR and Lowry CA and Mahfooz NS and McMichael TM and Merling MR and Miller MA and Nagajyothi JF and Nelson E and Nuermberger EL and Pena MT and Perea C and Podell BK and Pyle CJ and Quinn FD and Rajaram MV and Mejia OR and Rothoff M and Sago SA and Salvador LC and Simonson AW and Spencer JS and Sreevatsan S and Subbian S and Sunstrum J and Tobin DM and Vijayan K and Wright CT and Robinson RT},
  title = {The Many Hosts of Mycobacteria 9 (MHM9): A conference report},
  abstract = {<p>The Many Hosts of&nbsp;Mycobacteria&nbsp;(MHM) meeting series brings together basic scientists, clinicians and veterinarians to promote robust discussion and dissemination of recent advances in our knowledge of numerous mycobacterial&nbsp;diseases, including human and&nbsp;bovine tuberculosis&nbsp;(TB),&nbsp;nontuberculous mycobacteria&nbsp;(NTM) infection, Hansen's disease (leprosy),&nbsp;Buruli ulcer&nbsp;and&nbsp;Johne's disease. The 9th MHM conference (MHM9) was held in July 2022&nbsp;at The Ohio State University (OSU) and centered around the theme of “Confounders of Mycobacterial Disease.” Confounders can and often do drive the transmission of mycobacterial&nbsp;diseases, as well as impact surveillance and&nbsp;treatment&nbsp;outcomes. Various confounders were presented and discussed at MHM9 including those that originate from the host (comorbidities and coinfections) as well as those arising from the environment (e.g.,&nbsp;zoonotic&nbsp;exposures), economic inequality (e.g. healthcare disparities), stigma (a confounder of leprosy and TB for millennia), and historical neglect (a confounder in Native American Nations). This conference report summarizes select talks given at MHM9 highlighting recent research advances, as well as talks regarding the historic and ongoing impact of TB and other infectious diseases on Native American Nations, including those in Southwestern Alaska where the regional TB incidence rate is among the highest in the Western hemisphere.</p>
},
  year = {2023},
  journal = {Tuberculosis},
  volume = {142},
  publisher = {Elsevier BV},
  issn = {1472-9792},
  doi = {10.1016/j.tube.2023.102377},
  language = {Eng},
}